The Business Research Company’s Competitive Landscape Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035
LONDON, GREATER LONDON , UNITED KINGDOM, October 20, 2026 /EINPresswire.com/ — The intraoperative radiotherapy (IORT) sector is witnessing rapid advancements and expanding interest as it becomes a preferred method for treating cancer during surgery. With ongoing innovations and increasing demand for targeted therapies, this market is set to experience substantial growth in the coming years. Let’s explore the current market size, key factors propelling its expansion, regional dynamics, and emerging trends shaping the IORT landscape.
Market Size and Growth Outlook for the Intraoperative Radiotherapy Market
The intraoperative radiotherapy market has seen swift growth recently, expanding from $1.08 billion in 2025 to an anticipated $1.19 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.6%. This historical growth stems from factors such as rising cancer rates, increased demand for targeted radiation therapies, preference for shorter treatment durations, greater investments in advanced oncology facilities, and wider adoption of image-guided surgical techniques. Looking ahead, the market is projected to reach $1.75 billion by 2030, maintaining a strong CAGR of 10.1%. Future growth drivers include the increasing popularity of personalized cancer treatments, the need to minimize radiation exposure to healthy tissue, broader acceptance of intraoperative technologies, expansion of specialized oncology centers, and rising demand for single-session radiation therapies. Key market trends during this period involve the shift towards single-session treatments, heightened demand for precise radiation delivery during surgery, growing use of compact radiation devices, integration of treatment planning with dosimetry, and adoption of minimally invasive approaches.
Download a free sample of the intraoperative radiotherapy (iort) market report:
https://www.thebusinessresearchcompany.com/sample_request?id=47582043&type=smp&name=Intraoperative%20Radiotherapy%20%28IORT%29%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Oct_PR
Understanding the Intraoperative Radiotherapy Technique
Intraoperative radiotherapy (IORT) is a cutting-edge cancer treatment that administers a concentrated dose of ionizing radiation directly to the tumor or tumor bed during surgical removal. This technique allows for precise targeting of cancer cells while protecting adjacent healthy tissues from unnecessary radiation exposure. Additionally, IORT can reduce the patient’s need for follow-up external radiotherapy, making treatment more efficient and potentially improving outcomes in select cases.
Key Factors Fueling the Growth of the IORT Market
One of the primary drivers behind the expanding intraoperative radiotherapy market is the rising incidence of cancer worldwide. Cancer involves abnormal cell growth that can invade nearby tissues and spread throughout the body. The increasing prevalence is largely linked to an aging global population since older age is the greatest risk factor for most cancers, with a majority of new diagnoses occurring in individuals over 65. IORT enhances cancer care by delivering focused radiation during surgery, which improves precision, protects healthy tissues, and lowers the chance of local recurrence. For instance, in February 2024, the World Health Organization reported that new cancer cases are expected to reach more than 35 million by 2050—a 77% increase from 20 million cases recorded in 2022. This sharp rise in cancer incidence is a significant catalyst driving demand for intraoperative radiotherapy.
View the full intraoperative radiotherapy (iort) market report:
https://www.thebusinessresearchcompany.com/report/intraoperative-radiotherapy-iort-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Oct_PR
Which Geographical Markets Are Leading the IORT Industry?
In 2025, North America held the largest share of the intraoperative radiotherapy market, reflecting well-established oncology infrastructure and high adoption rates of advanced treatment technologies. Meanwhile, the Asia-Pacific region is anticipated to be the fastest-growing market throughout the forecast period, fueled by expanding healthcare investments, rising awareness, and improving access to cancer care. The market report covers a broad range of regions, including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of global market dynamics.
New strategic additions in our 2026 market reports include market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company – www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company.
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
